Soleno Therapeutics, Inc. · NASDAQ:SLNO
BlackRock, Inc.'s stake in Soleno Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc.'s stake in Soleno Therapeutics, Inc. fell to 4.70%, 2,009,790 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 2,009,790
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.70% | 2,009,790 |
Source
Related
- Soleno Therapeutics, Inc.
- BlackRock, Inc.
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 24, 2026
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026